Li D, Darden C, Osman N, Sayeed S, Jackson L, Garbinsky D, Chauhan A. Real-world clinical and patient-reported outcomes from the longitudinal telotristat ethyl treatment registry of patients with neuroendocrine tumors. Cancer Manag Res. 2022 Oct 17;14:3009-20. doi: 10.2147/CMAR.S386419
Hofheinz RD, Bruix J, Demetri GD, Grothey A, Marian M, Bartsch J, Odom D. Effect of regorafenib in delaying definitive deterioration in health-related quality of life in patients with advanced cancer of three different tumor types. Cancer Manag Res. 2021 Jul 12;13:5523-33. doi: 10.2147/CMAR.S305939
Cuyún Carter G, Barrett AM, Kaye JA, Liepa AM, Winfree KB, John WJ. A comprehensive review of nongenetic prognostic and predictive factors influencing the heterogeneity of outcomes in advanced non-small-cell lung cancer. Cancer Manag Res. 2014 Oct 23;2014(6):437-49. doi: 10.2147/CMAR.S63603
Stavisky RC, Watson SL, Anthony MS, Manuck SB, Adams MR, Kaplan JR. Influence of estradiol on cortisol secretion in ovariectomized cynomolgus macaques (Macaca fascicularis). Am J Primatol. 2003 May;60(1):17-22.
Stavisky RC, Ayers MR, Anthony MS, Hopkins WD, Andrews M, Kaplan JR. Assessment of cognitive performance in reproductively intact and ovariectomized monkeys. Am J Primatol. 1999;49(1):103.
Williams JK, Anthony MS, Clarkson TB. Coronary heart disease in rhesus monkeys with atherosclerosis. Poster presented at the 14th Annual Meeting of the American Society of Primatologists; June 1991. Veracruz, Mexico. [abstract] Am J Primatol. 1991 Jun; 24(2):140.
Miller LC, Anthony MS, Weingand KW, Clarkson TB. Development of nonhuman primate resource for atherosclerosis research. Poster presented at the Seventh Annual Meeting, American Society of Primatologists; June 1985. Niagara Falls, NY. [abstract] Am J Primatol. 1985 Jun; 8(4):353.